• DSRU Consultancy launched!

    We’re delighted to announce the launch of DSRU Consultancy: Pharmacovigilance, Pharmacoepidemiology and Risk Management. DSRU Consultancy provides advice on strategies, study designs and options for post-marketing Pharmacovigilance, Pharmacoepidemiology and Risk Management Planning. This initiative builds on the DSRU’s vast experience in studying a wide range medicines and working with companies of all sizes. The DSRU has […]

    >Continue reading
  • Report published on Signal Detection Conference

    The meeting report has just been published for our 9th Biennial Signal Detection Conference, which took place in June. The report details some of the highlights and themes of the event, including Signal Detection in the Age of Big Data, new methodologies and updates on well-established approaches. DSRU Signal Detection Conferences have built up a […]

    >Continue reading
  • DSRU’s 9th Signal Detection Conference is a great success!

    Our biennial Signal Detection Conferences have built up a loyal following in the pharmacovigilance community since the first conference in 2001. It was a pleasure to see many familiar faces at last week’s 9th Signal Detection Conference, as well as to welcome many newcomers. The majority of delegates attended the pre-conference tutorial day, which had been redesigned […]

    >Continue reading
  • BMJ feature on DSRU’s Brexit Forum

    Nigel Hawkes’ feature in the BMJ (http://www.bmj.com/content/357/bmj.j2168 published 17th May 2017) outlines some of the concerns raised at the DSRU’s Forum on UK Pharmacovigilance post-Brexit, which was held in London on 26th April. He notes that while the European Medicines Agency (EMA) would have to be relocated in order to remain within the EU, UK […]

    >Continue reading